Michael Geffner
Vermögen: 9 Mio $ am 30.06.2026
Vermögen: 9 Mio $ am 30.06.2026
Michael Geffner worked as Head-Global Medical Affairs at Achillion Pharmaceuticals, Inc. from 2015 to 2020.
Dr. Geffner worked as Principal at Merck & Co., Inc. Dr. Geffner worked as Chief Medical Officer & Head-Product Development at BlueSphere Bio, Inc. from 2020 to 2022.
Dr. Geffner worked as Principal at Clindevex Consulting, Inc. Dr. Geffner worked as Chief Medical Officer at Immunovant, Inc. Dr. Geffner earned an MBA from Fairleigh Dickinson University and a doctorate from Albany Medical College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOVANT INC 0,11 % | 30.06.2026 | 234.586 ( 0,11 % ) | 9 Mio $ | 30.06.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOVANT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 21.11.2025 |
BlueSphere Bio, Inc.
BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology drugs products | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2022 |
| ACHILLION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.04.2020 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albany Medical College
Albany Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BlueSphere Bio, Inc.
BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology drugs products | Health Technology |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen